The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Medicinal cannabis are also known as Medical marijuana, which area used either to treat disease or to improve their symptoms. The two cannabinoids - delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) are used in treatment of certain disease or health conditions such as pain, blood pressure, memory, concentration, appetite, sensory stimulus, muscular problems, and seizures.
The global Medical Cannabis market size is expected to reach US$ 30430 million by 2029, growing at a CAGR of 12.7% from 2023 to 2029. The market is mainly driven by the significant applications of Medical Cannabis in various end use industries. The expanding demands from the Pain, Arthritis, Neurological Disease (Epilepsy, Multiple Sclerosis and Other Neurological Applications) and Others, are propelling Medical Cannabis market. Tetrahydrocannabinol (THC), one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Cannabidiol (CBD) segment is estimated at % CAGR for the next seven-year period.
Legalization of cannabis across various regions and rise in awareness among consumers regarding health benefits of cannabis and its growing medical application such as treatment of wide range of diseases and symptoms, including cancer, chronic pain, depression, arthritis, diabetes, glaucoma, migraines, epilepsy, multiple sclerosis, acquired immunodeficiency syndrome (AIDS), amyotrophic lateral sclerosis (ALS), Alzheimer’s, post-traumatic stress disorder (PTSD), Parkinson’s, and Tourette’s drive the growth of the medical cannabis market. In addition, novel product development with increased R&D activities fuels growth of the market.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Medical Cannabis, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Medical Cannabis market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Medical Cannabis market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Medical Cannabis sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Medical Cannabis covered in this report include BOL Pharma, Tilray, Medreleaf Corporation, Aurora Cannabis, Inc, Canopy Growth Corporation, Insys Therapeutics, Inc, Aphria, Inc, MGC Pharmaceuticals Limited and GW Pharmaceuticals, plc, etc.
The global Medical Cannabis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
- BOL Pharma
- Tilray
- Medreleaf Corporation
- Aurora Cannabis, Inc
- Canopy Growth Corporation
- Insys Therapeutics, Inc
- Aphria, Inc
- MGC Pharmaceuticals Limited
- GW Pharmaceuticals, plc
- Medical Marijuana Inc
- Medipharm Labs
- Tikun Olam Ltd
- OrganiGram Holding Inc
- Maricann Group, Inc
- Terra Tech Corp
- Cronos Group Inc.
- VIVO Cannabis Inc.
- Cannabis Sativa, Inc.
Global Medical Cannabis market, by region:
- North America (U.S., Canada, Mexico)
- Europe (Germany, France, UK, Italy, etc.)
- Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
- South America (Brazil, etc.)
- Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Medical Cannabis market, Segment by Type:
- Tetrahydrocannabinol (THC)
- Cannabidiol (CBD)
Global Medical Cannabis market, by Application:
- Pain
- Arthritis
- Neurological Disease (Epilepsy, Multiple Sclerosis and Other Neurological Applications)
- Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Medical Cannabis manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Medical Cannabis in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index
1 Medical Cannabis Market Overview
1.1 Medical Cannabis Product Overview
1.2 Medical Cannabis Market Segment by Type
1.2.1 Tetrahydrocannabinol (THC)
1.2.2 Cannabidiol (CBD)
1.3 Global Medical Cannabis Market Size by Type
1.3.1 Global Medical Cannabis Market Size Overview by Type (2018-2029)
1.3.2 Global Medical Cannabis Historic Market Size Review by Type (2018-2023)
1.3.3 Global Medical Cannabis Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Medical Cannabis Sales Breakdown by Type (2018-2023)
1.4.2 Europe Medical Cannabis Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Medical Cannabis Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Medical Cannabis Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Medical Cannabis Sales Breakdown by Type (2018-2023)
2 Global Medical Cannabis Market Competition by Company
2.1 Global Top Players by Medical Cannabis Sales (2018-2023)
2.2 Global Top Players by Medical Cannabis Revenue (2018-2023)
2.3 Global Top Players by Medical Cannabis Price (2018-2023)
2.4 Global Top Manufacturers Medical Cannabis Manufacturing Base Distribution, Sales Area, Product Type
2.5 Medical Cannabis Market Competitive Situation and Trends
2.5.1 Medical Cannabis Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Medical Cannabis Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Medical Cannabis as of 2022)
2.7 Date of Key Manufacturers Enter into Medical Cannabis Market
2.8 Key Manufacturers Medical Cannabis Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Medical Cannabis Status and Outlook by Region
3.1 Global Medical Cannabis Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Medical Cannabis Historic Market Size by Region
3.2.1 Global Medical Cannabis Sales in Volume by Region (2018-2023)
3.2.2 Global Medical Cannabis Sales in Value by Region (2018-2023)
3.2.3 Global Medical Cannabis Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Medical Cannabis Forecasted Market Size by Region
3.3.1 Global Medical Cannabis Sales in Volume by Region (2024-2029)
3.3.2 Global Medical Cannabis Sales in Value by Region (2024-2029)
3.3.3 Global Medical Cannabis Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Medical Cannabis by Application
4.1 Medical Cannabis Market Segment by Application
4.1.1 Pain
4.1.2 Arthritis
4.1.3 Neurological Disease (Epilepsy, Multiple Sclerosis and Other Neurological Applications)
4.1.4 Others
4.2 Global Medical Cannabis Market Size by Application
4.2.1 Global Medical Cannabis Market Size Overview by Application (2018-2029)
4.2.2 Global Medical Cannabis Historic Market Size Review by Application (2018-2023)
4.2.3 Global Medical Cannabis Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Medical Cannabis Sales Breakdown by Application (2018-2023)
4.3.2 Europe Medical Cannabis Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Medical Cannabis Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Medical Cannabis Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Medical Cannabis Sales Breakdown by Application (2018-2023)
5 North America Medical Cannabis by Country
5.1 North America Medical Cannabis Historic Market Size by Country
5.1.1 North America Medical Cannabis Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Medical Cannabis Sales in Volume by Country (2018-2023)
5.1.3 North America Medical Cannabis Sales in Value by Country (2018-2023)
5.2 North America Medical Cannabis Forecasted Market Size by Country
5.2.1 North America Medical Cannabis Sales in Volume by Country (2024-2029)
5.2.2 North America Medical Cannabis Sales in Value by Country (2024-2029)
6 Europe Medical Cannabis by Country
6.1 Europe Medical Cannabis Historic Market Size by Country
6.1.1 Europe Medical Cannabis Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Medical Cannabis Sales in Volume by Country (2018-2023)
6.1.3 Europe Medical Cannabis Sales in Value by Country (2018-2023)
6.2 Europe Medical Cannabis Forecasted Market Size by Country
6.2.1 Europe Medical Cannabis Sales in Volume by Country (2024-2029)
6.2.2 Europe Medical Cannabis Sales in Value by Country (2024-2029)
7 Asia-Pacific Medical Cannabis by Region
7.1 Asia-Pacific Medical Cannabis Historic Market Size by Region
7.1.1 Asia-Pacific Medical Cannabis Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Medical Cannabis Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Medical Cannabis Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Medical Cannabis Forecasted Market Size by Region
7.2.1 Asia-Pacific Medical Cannabis Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Medical Cannabis Sales in Value by Region (2024-2029)
8 Latin America Medical Cannabis by Country
8.1 Latin America Medical Cannabis Historic Market Size by Country
8.1.1 Latin America Medical Cannabis Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Medical Cannabis Sales in Volume by Country (2018-2023)
8.1.3 Latin America Medical Cannabis Sales in Value by Country (2018-2023)
8.2 Latin America Medical Cannabis Forecasted Market Size by Country
8.2.1 Latin America Medical Cannabis Sales in Volume by Country (2024-2029)
8.2.2 Latin America Medical Cannabis Sales in Value by Country (2024-2029)
9 Middle East and Africa Medical Cannabis by Country
9.1 Middle East and Africa Medical Cannabis Historic Market Size by Country
9.1.1 Middle East and Africa Medical Cannabis Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Medical Cannabis Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Medical Cannabis Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Medical Cannabis Forecasted Market Size by Country
9.2.1 Middle East and Africa Medical Cannabis Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Medical Cannabis Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 BOL Pharma
10.1.1 BOL Pharma Company Information
10.1.2 BOL Pharma Introduction and Business Overview
10.1.3 BOL Pharma Medical Cannabis Sales, Revenue and Gross Margin (2018-2023)
10.1.4 BOL Pharma Medical Cannabis Products Offered
10.1.5 BOL Pharma Recent Development
10.2 Tilray
10.2.1 Tilray Company Information
10.2.2 Tilray Introduction and Business Overview
10.2.3 Tilray Medical Cannabis Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Tilray Medical Cannabis Products Offered
10.2.5 Tilray Recent Development
10.3 Medreleaf Corporation
10.3.1 Medreleaf Corporation Company Information
10.3.2 Medreleaf Corporation Introduction and Business Overview
10.3.3 Medreleaf Corporation Medical Cannabis Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Medreleaf Corporation Medical Cannabis Products Offered
10.3.5 Medreleaf Corporation Recent Development
10.4 Aurora Cannabis, Inc
10.4.1 Aurora Cannabis, Inc Company Information
10.4.2 Aurora Cannabis, Inc Introduction and Business Overview
10.4.3 Aurora Cannabis, Inc Medical Cannabis Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Aurora Cannabis, Inc Medical Cannabis Products Offered
10.4.5 Aurora Cannabis, Inc Recent Development
10.5 Canopy Growth Corporation
10.5.1 Canopy Growth Corporation Company Information
10.5.2 Canopy Growth Corporation Introduction and Business Overview
10.5.3 Canopy Growth Corporation Medical Cannabis Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Canopy Growth Corporation Medical Cannabis Products Offered
10.5.5 Canopy Growth Corporation Recent Development
10.6 Insys Therapeutics, Inc
10.6.1 Insys Therapeutics, Inc Company Information
10.6.2 Insys Therapeutics, Inc Introduction and Business Overview
10.6.3 Insys Therapeutics, Inc Medical Cannabis Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Insys Therapeutics, Inc Medical Cannabis Products Offered
10.6.5 Insys Therapeutics, Inc Recent Development
10.7 Aphria, Inc
10.7.1 Aphria, Inc Company Information
10.7.2 Aphria, Inc Introduction and Business Overview
10.7.3 Aphria, Inc Medical Cannabis Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Aphria, Inc Medical Cannabis Products Offered
10.7.5 Aphria, Inc Recent Development
10.8 MGC Pharmaceuticals Limited
10.8.1 MGC Pharmaceuticals Limited Company Information
10.8.2 MGC Pharmaceuticals Limited Introduction and Business Overview
10.8.3 MGC Pharmaceuticals Limited Medical Cannabis Sales, Revenue and Gross Margin (2018-2023)
10.8.4 MGC Pharmaceuticals Limited Medical Cannabis Products Offered
10.8.5 MGC Pharmaceuticals Limited Recent Development
10.9 GW Pharmaceuticals, plc
10.9.1 GW Pharmaceuticals, plc Company Information
10.9.2 GW Pharmaceuticals, plc Introduction and Business Overview
10.9.3 GW Pharmaceuticals, plc Medical Cannabis Sales, Revenue and Gross Margin (2018-2023)
10.9.4 GW Pharmaceuticals, plc Medical Cannabis Products Offered
10.9.5 GW Pharmaceuticals, plc Recent Development
10.10 Medical Marijuana Inc
10.10.1 Medical Marijuana Inc Company Information
10.10.2 Medical Marijuana Inc Introduction and Business Overview
10.10.3 Medical Marijuana Inc Medical Cannabis Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Medical Marijuana Inc Medical Cannabis Products Offered
10.10.5 Medical Marijuana Inc Recent Development
10.11 Medipharm Labs
10.11.1 Medipharm Labs Company Information
10.11.2 Medipharm Labs Introduction and Business Overview
10.11.3 Medipharm Labs Medical Cannabis Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Medipharm Labs Medical Cannabis Products Offered
10.11.5 Medipharm Labs Recent Development
10.12 Tikun Olam Ltd
10.12.1 Tikun Olam Ltd Company Information
10.12.2 Tikun Olam Ltd Introduction and Business Overview
10.12.3 Tikun Olam Ltd Medical Cannabis Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Tikun Olam Ltd Medical Cannabis Products Offered
10.12.5 Tikun Olam Ltd Recent Development
10.13 OrganiGram Holding Inc
10.13.1 OrganiGram Holding Inc Company Information
10.13.2 OrganiGram Holding Inc Introduction and Business Overview
10.13.3 OrganiGram Holding Inc Medical Cannabis Sales, Revenue and Gross Margin (2018-2023)
10.13.4 OrganiGram Holding Inc Medical Cannabis Products Offered
10.13.5 OrganiGram Holding Inc Recent Development
10.14 Maricann Group, Inc
10.14.1 Maricann Group, Inc Company Information
10.14.2 Maricann Group, Inc Introduction and Business Overview
10.14.3 Maricann Group, Inc Medical Cannabis Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Maricann Group, Inc Medical Cannabis Products Offered
10.14.5 Maricann Group, Inc Recent Development
10.15 Terra Tech Corp
10.15.1 Terra Tech Corp Company Information
10.15.2 Terra Tech Corp Introduction and Business Overview
10.15.3 Terra Tech Corp Medical Cannabis Sales, Revenue and Gross Margin (2018-2023)
10.15.4 Terra Tech Corp Medical Cannabis Products Offered
10.15.5 Terra Tech Corp Recent Development
10.16 Cronos Group Inc.
10.16.1 Cronos Group Inc. Company Information
10.16.2 Cronos Group Inc. Introduction and Business Overview
10.16.3 Cronos Group Inc. Medical Cannabis Sales, Revenue and Gross Margin (2018-2023)
10.16.4 Cronos Group Inc. Medical Cannabis Products Offered
10.16.5 Cronos Group Inc. Recent Development
10.17 VIVO Cannabis Inc.
10.17.1 VIVO Cannabis Inc. Company Information
10.17.2 VIVO Cannabis Inc. Introduction and Business Overview
10.17.3 VIVO Cannabis Inc. Medical Cannabis Sales, Revenue and Gross Margin (2018-2023)
10.17.4 VIVO Cannabis Inc. Medical Cannabis Products Offered
10.17.5 VIVO Cannabis Inc. Recent Development
10.18 Cannabis Sativa, Inc.
10.18.1 Cannabis Sativa, Inc. Company Information
10.18.2 Cannabis Sativa, Inc. Introduction and Business Overview
10.18.3 Cannabis Sativa, Inc. Medical Cannabis Sales, Revenue and Gross Margin (2018-2023)
10.18.4 Cannabis Sativa, Inc. Medical Cannabis Products Offered
10.18.5 Cannabis Sativa, Inc. Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Medical Cannabis Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Medical Cannabis Industrial Chain Analysis
11.4 Medical Cannabis Market Dynamics
11.4.1 Medical Cannabis Industry Trends
11.4.2 Medical Cannabis Market Drivers
11.4.3 Medical Cannabis Market Challenges
11.4.4 Medical Cannabis Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Medical Cannabis Distributors
12.3 Medical Cannabis Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
